
Validea's guru fundamental report assigns MCKESSON CORP (MCK), a large-cap growth stock in the Major Drugs industry, a 100% rating from Pim van Vliet's Multi-Factor Investor model. This model targets low volatility stocks, which have historically demonstrated outperformance with reduced risk, indicating MCK's strong alignment with a strategy focused on conservative, high-return factor investing.
McKesson Corp (MCK) has received a maximum 100% rating from Validea's quantitative model based on Pim van Vliet's Multi-Factor Investor strategy, signaling strong alignment with a profile that seeks low-risk outperformance. The strategy prioritizes low volatility, strong momentum, and high net payout yield. MCK successfully passed the model's criteria for market capitalization and standard deviation, confirming its low-volatility characteristic, which is the cornerstone of this investment philosophy. However, the analysis also reveals neutral scores for 'Twelve Minus One Momentum' and 'Net Payout Yield'. The perfect final score, despite these neutral elements, suggests that the model places significant weight on the low-risk factors where MCK excels, positioning it as a compelling large-cap growth stock within the Major Drugs industry for conservative, factor-driven investors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment